Zobrazeno 1 - 10
of 25
pro vyhledávání: '"George Ilonidis"'
Publikováno v:
Liver International. 31:1071-1080
The most frequent kidney disease associated with chronic hepatitis C virus (HCV) infection is membranoproliferative glomerulonephritis in patients with type II mixed cryoglobulinaemia. The principal clinical manifestations of glomerular disease in HC
Autor:
Christos Lafaras, Dimitrios Platogiannis, Eudokia Mandala, George Ilonidis, Nikolaos Barbetakis, Athanasios N. Saratzis, Theodoros Bischiniotis, Panagiotis P. Paraskevopoulos
Publikováno v:
Onkologie. 33:300-304
The primary aim of this study was to evaluate a combined therapeutic intervention, including the dual endothelin receptor antagonist bosentan, in patients with carcinoid heart disease (CaHD). The efficacy of the treatment protocol was investigated us
Autor:
Efstratios K. Theofilogiannakos, Petros Glouftsios, Apostolos I. Hatzitolios, George Anogianakis, George Ilonidis, Antonia Anogeianaki, Panagiota Tsekoura
Publikováno v:
Journal of Cardiovascular Medicine. 9:89-93
OBJECTIVE Fatal arrhythmias are a common cause of death in chronic obstructive pulmonary disease (COPD). Two major hypotheses for arrhythmogenesis in COPD have been proposed: arrhythmias are a consequence of hypoxaemia, hypercapnia or (tissue localis
Autor:
Theodoros Kontakiotis, Ioanna Ahanasiou, George Ilonidis, Georgia Pitsiou, Afroditi K. Boutou, Ioannis Kioumis, Athanasia Pataka, Nikolaos Chavouzis, Paraskevi Argyropoulou, Katalin Fekete
Publikováno v:
7.1 Paediatric Respiratory Physiology and Sleep.
Rationale: Data on the impact of obstructive sleep apnea syndrome (OSAS) and its treatment on resting energy expenditure (REE) are currently few and conflicting. The purpose of the present study was to investigate, for the first time, the impact of a
Autor:
C. Giannakoylas, Antonia Anogeianaki, George Anogianakis, Efstratios K. Theofilogiannakos, D. Economidis, George Ilonidis, M. Trakatelli
Publikováno v:
European Journal of Inflammation, Vol 3 (2005)
We studied systemic reactions associated with immunotherapy in a group of 50 patients with mean age 31.4 years. The group consisted of 36 women and 14 men who followed a three-year immunotherapy treatment with pollen and mite allergen extracts (HAL-H
Autor:
P. Koumpoudis, Chr. Trakatelli, M. Trakatelli, C. Arvanitakis, George Ilonidis, J. Agorastos, George Anogianakis, Antonia Anogeianaki
Publikováno v:
European Journal of Inflammation, Vol 2 (2004)
Pulmonary complications have been described in patients with inflammatory bowel disease. The aim of this study was to evaluate bronchial hyppersponsiveness (BHR) in patients with Crohn's disease (CD) and ulcerative colitis (UC). Fifteen patients (8 m
Autor:
I. Michalis, M. Trakatellis, George Ilonidis, Chr. Trakatelli, Antonia Anogeianaki, George Anogianakis, J. Giavazis
Publikováno v:
European Journal of Inflammation, Vol 1 (2003)
Thirty subjects (20 female and 10 male), all allergic to the mites D. Pteronyssinus and D. Farinae, participated in the present study which covered a period of four years. The subjects were randomly divided in two groups. Group I included 10 female a
Autor:
Constantine Tatsis, Kyriakos Katsaros, Antonia Anogeianaki, George Anogianakis, Anelia Klisarova, Temel Temelkov, John Lianguris, Dimitra Pseftogianni, George Ilonidis
Publikováno v:
Journal of Telemedicine and Telecare. 10:4-6
In most Balkan countries, with the exception of Greece, transplantation is very rare and equality of access does not exist. In 2003, a Balkan partnership was established called SETNET (South-Eastern European Transplantation Network) for the promotion
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 31(8)
The most frequent kidney disease associated with chronic hepatitis C virus (HCV) infection is membranoproliferative glomerulonephritis in patients with type II mixed cryoglobulinaemia. The principal clinical manifestations of glomerular disease in HC
Autor:
George Ilonidis, Evangelos Cholongitas
Publikováno v:
American journal of infection control. 38(8)